Transaction · 0001159036-26-000117
HALOHALOZYME THERAPEUTICS, INC.
Appelhans Dannielle
Appelhans Dannielle, DIR, reported a transaction classified as grant at HALOZYME THERAPEUTICS, INC. involving 1778.000000 shares for an estimated $0.00. Reported holdings after the transaction were 1778.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
grantSEC transaction code ADIR
- Trade date
- Sep 01, 2026
- Filing date
- Sep 02, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
HALO price since this filing
Daily closing prices, with the filing date and available return windowsHALO · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -24.7%1w ago -0.6%1d ago -2.9%
Returns since7d -2.1%30d +0.2%90d180d1y
Transaction facts
Stored Form 4 columns with their raw values
- Type
- grant Code A
- Identifier
- 0001159036-26-000117 Option to Purchase Common Stock
- Transaction date
- Sep 01, 2026 Filed Sep 02, 2026, 08:59 PM · 1d delay
- Shares
- 1,778 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 1,778 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership Large Holdings Increase
Filing-only score
-6 points
Compact filing score computed from stored Form 4 facts. Version v1.
Mixed or weak signal
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 1
Filing reported within two business days of the transaction. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Reported roles
No officer title
Officer NoDirector Yes10% NoOther No
Footnotes & amended
- F1
Represents restricted stock units granted under the Issuer's director compensation program. Each stock unit represents the right to receive one share of common stock and is scheduled to vest on the
date of the Issuer's 2027 annual meeting of stockholders.
- F2
Represents stock options granted under the Issuer's director compensation program. This grant will vest in full on the date of the Issuer's 2027 annual meeting of stockholders.
Related transactions
Same SEC filing0 other transactions
Recent company activity
HALO0 recent txs